Neurogenic progression may falter in MDD - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Neurogenic progression may falter in MDD

  • By

  • Andrea Surnit

  • August 26, 2026

  • 4 min

Share

  • 1

    Patients with major depressive disorder (MDD) exhibited disrupted adult hippocampal neurogenesis, with stalled progression from neural stem-like cells to neuroblasts.

  • 2

    Postmortem analysis included hippocampal tissue from 123 patients, with a focus on 19 controls and 11 patients with MDD for multiomic analysis.

  • 3

    Pseudotime analysis revealed a shift in cell distribution in MDD patients, showing more quiescent neural stem cells and fewer neuroblasts compared to controls.

  • 4

    Molecular alterations in MDD included increased expression of an interferon-related gene module and reduced expression of neurogenesis-related genes in neuroblasts.

  • 5

    The study's limitations included its cross-sectional design and challenges in distinguishing MDD-related pathology from suicide-related pathology.

Original Source(s)

Related Content